Move over metrosexuals and lumbersexuals. The new guy in town is a spornosexual. He’s buff, isn’t afraid to admit to using moisturizers and has the confidence to make his own decisions about facial hair. He might grow out a beard during No-Shave November and go sleek the next month.
For many people, sleep does not always come easily. Pain and a host of other problems can often make it difficult — if not impossible — to fall asleep. Temporary sleeping problems, in turn, can cause a tired mind and lead to headaches and body pains that make it even harder to get a good night’s sleep.
With an estimated 60 million people in the United States experiencing heartburn at least once a month, and more than 15 million suffering from it daily, products to treat the condition have become more sophisticated, and the battle for supremacy in the $2.18 billion-a-year antacid tablets market has grown more heated.
Last month’s launch of the first generic biologic drug in the United States is the first step in a movement that some say could drive down the nation’s healthcare bill and bring new treatment options to thousands of patients across the country.
Drug Store News editor Rob Eder delivered the keynote address at the Brazilian Association of Pharmacies and Drugstore Networks — otherwise known as Abrafarma — at the group’s second annual Abrafarma Future Trends conference in Sao Paolo on Sept. 8